Publications

• Part 2 – Helpful Guidance on Managing (Non-Cybersecurity) AI Risks from Hong Kong’s SFC
  22 November 2024
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Gareth Hughes
  ,
  Erez Liebermann
  ,
  Matt Kelly
  ,
  Emily Lam
  ,
  Suchita Mandavilli Brundage
• Helpful Guidance on Managing AI-Related Cybersecurity Risks from Hong Kong’s SFC
  19 November 2024
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Gareth Hughes
  ,
  Erez Liebermann
  ,
  Matt Kelly
  ,
  Emily Lam
  ,
  Suchita Mandavilli Brundage
• SEC Targets AI Washing in Private Capital Markets: “Old School Fraud Using New School Buzzwords”
  14 June 2024
  Andrew J. Ceresney
  ,
  Charu A. Chandrasekhar
  ,
  Avi Gesser
  ,
  Julie M. Riewe
  ,
  Kristin A. Snyder
  ,
  Matt Kelly
  ,
  Suchita Mandavilli Brundage
• The SEC Adopts Significant Cybersecurity Amendments to Reg S-P
  17 May 2024
  Charu A. Chandrasekhar
  ,
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Erez Liebermann
  ,
  Marc Ponchione
  ,
  Julie M. Riewe
  ,
  Jeff Robins
  ,
  Kristin A. Snyder
  ,
  Anna Moody
  ,
  Sheena Paul
  ,
  Johanna N. Skrzypczyk
  ,
  Suchita Mandavilli Brundage
  ,
  Ned Terrace
• Generative AI: Risks and Considerations for Private Equity
  May 2023
  Avi Gesser
  ,
  Kristin A. Snyder
  ,
  Charu A. Chandrasekhar
  ,
  Matt Kelly
  ,
  Suchita Mandavilli Brundage
• Private Equity Report Spring 2023, Vol 23, No 1
  May 2023
  Michael Bolotin
  ,
  Jennifer L. Chu
  ,
  Avi Gesser
  ,
  Meir D. Katz
  ,
  Henry Lebowitz
  ,
  Marc Ponchione
  ,
  Kevin M. Schmidt
  ,
  Shannon Rose Selden
  ,
  Scott B. Selinger
  ,
  Kristin A. Snyder
  ,
  Matthew J. Sorensen
  ,
  Charu A. Chandrasekhar
  ,
  Matt Kelly
  ,
  Caroline P. Geiger
  ,
  Sheena Paul
  ,
  Keith J. Slattery
  ,
  Suchita Mandavilli Brundage
  ,
  Tigist Kassahun
  ,
  Dominique Trudelle
  ,
  Massy Vainshtein
• NYU Compliance & Enforcement: The Value of Having AI Governance – Lessons from ChatGPT
  10 April 2023
  NYU Compliance & Enforcement
  Avi Gesser
  ,
  Suchita Mandavilli Brundage
  ,
  Samuel J. Allaman
• NYU Compliance & Enforcement: A Late Winter Blizzard of SEC Cybersecurity Rulemaking: the Proposed BD Cybersecurity Rules and Expanded Reg S-P and Reg SCI Obligations
  30 March 2023
  NYU Compliance & Enforcement
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Erez Liebermann
  ,
  Marc Ponchione
  ,
  Julie M. Riewe
  ,
  Jeff Robins
  ,
  Kristin A. Snyder
  ,
  Charu A. Chandrasekhar
  ,
  Sheena Paul
  ,
  Suchita Mandavilli Brundage
  ,
  Mengyi Xu
  ,
  Ned Terrace
• A Late Winter Blizzard of SEC Cybersecurity Rulemaking: the Proposed BD Cybersecurity Rules and Expanded Reg S-P and Reg SCI Obligations
  20 March 2023
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Erez Liebermann
  ,
  Marc Ponchione
  ,
  Julie M. Riewe
  ,
  Jeff Robins
  ,
  Kristin A. Snyder
  ,
  Charu A. Chandrasekhar
  ,
  Sheena Paul
  ,
  Suchita Mandavilli Brundage
  ,
  Mengyi Xu
  ,
  Ned Terrace
• Preparing for the SEC’s Cybersecurity Rules for Registered Investment Advisers, Registered Investment Companies, and Business Development Companies
  13 March 2023
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Erez Liebermann
  ,
  Julie M. Riewe
  ,
  Kristin A. Snyder
  ,
  Charu A. Chandrasekhar
  ,
  Suchita Mandavilli Brundage
  ,
  Jarrett Lewis
• Harvard Law School Forum on Corporate Governance: The SEC’s Cyber Priorities and Four Ways for Companies to Reduce Regulatory Risk
  11 August 2021
  Harvard Law School Forum on Corporate Governance
  Avi Gesser
  ,
  Johanna N. Skrzypczyk
  ,
  Suchita Mandavilli Brundage
• The SEC’s Cyber Priorities and Four Additional Ways for Companies to Reduce Regulatory Risk
  29 July 2021
  Avi Gesser
  ,
  Johanna N. Skrzypczyk
  ,
  Suchita Mandavilli Brundage
• COVID-19: FDA Developments and Legal Considerations for Healthcare and Life Science Companies and Investors
  17 March 2020
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Paul D. Rubin
  ,
  Jacob W. Stahl
  ,
  Suchita Mandavilli Brundage
  ,
  Melissa Runsten
• In re: Marriott International Inc., Customer Data Security Breach Litigation
  27 February 2020
  Luke Dembosky
  ,
  Avi Gesser
  ,
  Jim Pastore
  ,
  Suchita Mandavilli Brundage
• Indian Pharma: Congress and FDA Continue Scrutiny of Foreign Drug Companies with Heightened Focus on Companies Located in India
  12 February 2020
  Andrew L. Bab
  ,
  Geoffrey P. Burgess
  ,
  Jennifer L. Chu
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Suchita Mandavilli Brundage
  ,
  Melissa Runsten